These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18460523)

  • 1. Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting.
    Sirak TE; Sherrid MV
    Chest; 2008 May; 133(5):1243-6. PubMed ID: 18460523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide.
    Haruki S; Minami Y; Suzuki A; Hagiwara N
    Heart Vessels; 2015 Sep; 30(5):604-10. PubMed ID: 24917414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
    Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
    Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intraoperative diagnosis of dynamic left ventricular outflow tract obstruction using transesophageal echocardiography leads to the treatment with intravenous disopyramide.
    Ashidagawa M; Ohara M; Koide Y
    Anesth Analg; 2002 Feb; 94(2):310-2, table of contents. PubMed ID: 11812689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.
    Verlinden NJ; Coons JC
    Pharmacotherapy; 2015 Dec; 35(12):1164-72. PubMed ID: 26684556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy.
    Ranasinghe I; Yeoh T; Yiannikas J
    Heart Lung Circ; 2011 Sep; 20(9):579-86. PubMed ID: 21684204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of continuous intravenous drip infusion of disopyramide in hypertrophic obstructive cardiomyopathy during cardiogenic shock: a case report].
    Kajimoto K; Harada T; Imamura K; Matsuda N; Niki K; Hagiwara N; Kasanuki H
    J Cardiol; 2000 Mar; 35(3):197-203. PubMed ID: 10808427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography imaging to quantify the area of the endocardial subvalvular apparatus in hypertrophic cardiomyopathy - Relationship to outflow tract obstruction and symptoms.
    Tajima M; Iguchi N; Utanohara Y; Hiroi Y; Mahara K; Niwa T; Takayama M; Sumiyoshi T; Tomoike H
    J Cardiovasc Comput Tomogr; 2016; 10(5):351-8. PubMed ID: 27498132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
    Malik R; Maron MS; Rastegar H; Pandian NG
    Echocardiography; 2014 May; 31(5):682-5. PubMed ID: 24649889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
    Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
    Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of responsiveness to disopyramide in patients with hypertrophic cardiomyopathy.
    Habib M; Hoss S; Bruchal-Garbicz B; Chan RH; Rakowski H; Williams L; Adler A
    Int J Cardiol; 2019 Dec; 297():75-82. PubMed ID: 31615649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
    Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
    Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    McIntosh CL; Maron BJ; Cannon RO; Klues HG
    Circulation; 1992 Nov; 86(5 Suppl):II60-7. PubMed ID: 1424035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.
    Niki K; Sugawara M; Tanino S; Iwade K; Hosoda S; Kasanuki H
    Heart Vessels; 1999; 14(2):72-81. PubMed ID: 10651183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.
    Duncan WJ; Tyrrell MJ; Bharadwaj BB
    Can J Cardiol; 1991 Mar; 7(2):81-6. PubMed ID: 2049687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide use in infants and children with hypertrophic cardiomyopathy.
    O'Connor MJ; Miller K; Shaddy RE; Lin KY; Hanna BD; Ravishankar C; Rossano JW
    Cardiol Young; 2018 Apr; 28(4):530-535. PubMed ID: 29513203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Arabadjian M
    Prog Cardiovasc Dis; 2012; 54(6):483-92. PubMed ID: 22687589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.